Current role
Drug Manufacturers - General · Healthcare
Chief Accounting Officer
2025-03-12–present
Diane E. Wilfong
Chief Accounting Officer
Gilead Sciences, Inc. (GILD)Equibles does not estimate personal net worth.
Get an email with a short summary when Gilead Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get GILD alertsAbout Diane E. Wilfong
Diane E. Wilfong is recorded as Chief Accounting Officer at Gilead Sciences, Inc. (GILD) since March 12, 2025. Gilead Sciences, Inc. reported in an 8-K filed March 12, 2025 that Diane E. Wilfong was appointed interim Corporate Controller and Chief Accounting Officer, effective March 12, 2025. Gilead Sciences, Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Gilead Sciences, Inc. includes Daniel P. O’Day (CEO), Robin L. Washington (CFO), Erin Burkhart (Chief Accounting Officer) and 7 others.
“The Company's Board of Directors has appointed Diane E. Wilfong as the Company's interim Corporate Controller and Chief Accounting Officer, and designated her as the interim principal accounting officer, effective immediately.”
Affiliation history
-
Current
2025-03-12–present
Company network
Leadership on record at Gilead Sciences, Inc.
- Daniel P. O’Day CEO
- Robin L. Washington CFO
- Erin Burkhart Chief Accounting Officer
- Sandra Patterson Chief Accounting Officer
- Anthony Welters Board Member
- JEFFREY A. BLUESTONE Board Member
- Jacqueline K. Barton Board Member
- Javier J. Rodriguez Board Member
- SANDRA J. HORNING Board Member
- Ted W. Love, M.D. Board Member